goralatide has been researched along with Cardiomyopathies, Primary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attwood, KM; Dahal, S; Nguyen, J; Pokharel, S; Sexton, S; Sharma, UC; Singh, AK; Sonkawade, SD; Spernyak, JA; van Berlo, JH | 1 |
| Cuculich, P; Lenihan, DJ | 1 |
| Bombardi, C; Castoldi, G; Corradi, B; di Gioia, CR; Leopizzi, M; Mancini, M; Perego, C; Perego, L; Perlini, S; Stella, A; Zerbini, G | 1 |
3 other study(ies) available for goralatide and Cardiomyopathies, Primary
| Article | Year |
|---|---|
A Small Peptide Ac-SDKP Inhibits Radiation-Induced Cardiomyopathy.
Topics: Animals; Apoptosis; Cardiomyopathies; Cardiotoxicity; Collagen Type I; Collagen Type III; Disease Models, Animal; Extracellular Matrix; Female; Fibrosis; Galectin 3; Macrophages; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Oligopeptides; Radiation Injuries; Radiation-Protective Agents; Rats, Sprague-Dawley; RAW 264.7 Cells; Transforming Growth Factor beta1; Ventricular Function, Left | 2018 |
Cardioprotection During Therapeutic Radiation Treatment.
Topics: Cardiomyopathies; Cardiotoxicity; Heart Failure; Humans; Oligopeptides; Peptides | 2018 |
Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathies; Diabetes Complications; Diabetes Mellitus, Experimental; Fibrosis; Heart Ventricles; Hypoglycemic Agents; Insulin; Male; Myocardium; Oligopeptides; Ramipril; Rats; Rats, Sprague-Dawley; Smad Proteins; Transforming Growth Factor beta1 | 2009 |